Keywords: اینترلوکین; BMC; Boston Medical Center; EBV; Epstein-Barr virus; IgH; heavy-chain immunoglobulin; IL; interleukin; MERSI; Massachusetts Eye Research and Surgery Institution; PCR; polymerase chain reaction; TMC; Tufts Medical Center;
مقالات ISI اینترلوکین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین; AMPK; AMP-activated protein kinase; ACC; acetyl-CoAcarboxylase; COX; cyclooxygenase; CDK; cyclin-dependent kinase; CaMK; Ca2+/calmodulin-dependent protein kinase; CPT; Cholinephosphotransferase; Egr; early growth response gene; ERK; extracellular signal-r
Keywords: اینترلوکین; Allergic conjunctivitis; Chemokine receptor; Genomics; Interleukin; Matrix metalloproteinase; Proteomics; Vernal keratoconjunctivitis
Keywords: اینترلوکین; AID; autoimmune disorders; AF; adjuvant formulations; ASIA; autoimmune/inflammatory syndrome induced by adjuvants; CFA; complete Freundâ²s adjuvant; CIA; collagen-induced arthritis; DA; dark Agouti; DC; dendritic cells; EAE; experimental autoimmune encep
Keywords: اینترلوکین; Andro; Andrographolide; DR; diabetic retinopathy; STZ; streptozotocin; NPDR; non-proliferative DR; PDR; proliferative DR; CD31; cluster of differentiation 31; BRB; blood-retinal barrier; VEGF; vascular endothelial growth factor; ELISA; enzyme-linked immun
Keywords: اینترلوکین; Celiac Disease; HLA; T Cell; CD4; Intraepithelial Lymphocyte; Intestinal Epithelial Cell; Immunology; IEC; intestinal epithelial cells; IEL; intraepithelial lymphocytes; IFN; interferon; IL; interleukin; ILC; innate lymphoid cell; MMP; matrix metallopepti
Keywords: اینترلوکین; diabetes mellitus; insulin; metformin; psoriasis; thiazolidinedione; CI; confidence interval; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; IL; interleukin; LHID; Longitudinal Health Insurance Dataset; NHIRD; N
Keywords: اینترلوکین; DAPI; 4â²,6-diamidino-2-phenylindole; Iba-1; ionized calcium binding adaptor molecule-1; IL; interleukin; iNOS; inducible nitric oxide synthase; LPS; lipopolysaccharide; NF-κB; nuclear transcription factor kappa B; NO; nitric oxide; PrPC; prion protein;
Keywords: اینترلوکین; Sepsis; Fish oil; Parenteral nutrition; T-lymphocyte subsets; Immune function; Cytokines; ALI; ALI; acute lung injury; CLP; cecal ligation and puncture; FO; fish oil; IgA; immunoglobulin A; IL; interleukin; mAb; monoclonal antibody; NS; normal saline; PCR
Keywords: اینترلوکین; Asthma; Inhaled steroids; Smokers; Sputum mediators; Statins; ACQ; asthma control questionnaire; AQLQ; asthma quality of life questionnaire; ATS; American Thoracic Society; BMI; body mass index; CCL; chemokine (C-C motif) ligand; CXCL; chemokine (C-X-C mo
Keywords: اینترلوکین; AGA; appropriate-for-gestational-age; AHEI; alternate healthy eating index; ALT; alanine transaminase; AST; aspartate transaminase; AMPK; 5' adenosine monophosphate-activated protein kinase; aMED; alternate Mediterranean diet score; BMI; body mass index;
Keywords: اینترلوکین; cardiopulmonary bypass; hyperglycemia; hyperinsulinemia; insulin resistance; pediatrics; CI; confidence interval; CIH; critical illness hyperglycemia; CPB; cardiopulmonary bypass; EST; estimate; ICU; intensive care unit; IL; interleukin; IQR; interquartil
Keywords: اینترلوکین; RDN; reduning injection; LPS; lipopolysaccharide; URTIs; upper respiratory tract infections; PG; prostaglandin; NO; nitric oxide; COX; cyclooxygenase; iNOS; inducible NO synthase; IL; interleukin; TNF-α; tumor necrosis factor-α; TLR; Toll-like receptor;
Keywords: اینترلوکین; apo; apolipoprotein; HDL; high-density lipoprotein; HNF-1α,4α; hepatocyte nuclear factor-1α,4α; LRH-1; liver receptor homolog-1; Foxa2; forkhead box A2; PAF; platelet activating factor; LXR; liver X receptor; RXR; retinoid X receptor; FXR; farnesoid X
Keywords: اینترلوکین; Cutaneous lupus erythematous; Ultraviolet light; Interferon; Interleukin; Tumor necrosis factor-alpha;
Keywords: اینترلوکین; NHK; normal human keratinocyte; qRT-PCR; quantitative reverse transcription polymerase chain reaction; pDC; plasmacytoid dendritic cells; mDC; myeloid dendritic cell; MO-DC; monocyte-derived dendritic cell; APC; antigen-presenting cell; TLR; Toll-like rec
Keywords: اینترلوکین; BCA; bicinchoninic acid; bFGF; basic fibroblast growth factor; IL; interleukin; IL-1ra; interleukin 1 receptor antagonist; IFN-γ; interferon gamma; IP-10; interferon gamma-induced protein 10; G-CSF; granulocyte colony stimulating factor; GM-CSF; granuloc
Keywords: اینترلوکین; Juvenile idiopathic arthritis; Physical exercise; Pro-anti-inflammatory balance; Interleukin; miRNA; Calprotectin
Keywords: اینترلوکین; BMMC; bone marrow derived mast cell; BMCP; basophil/mast cell progenitor; CCR; CC chemokine receptor; CLP; common lymphoid progenitor; CMP; common myeloid progenitor; CXCR; CXC chemokine receptor; IL; interleukin; Linâ; lineageâ; MAdCAM-1; mucosal vas
Keywords: اینترلوکین; Asthma; Biologics; Therapeutics; AQLQs; Asthma quality of life questionnaires; EPR3; Expert Panel Report 3; FEV1; Forced expiratory volume in 1 second; FENO; Fractional exhaled nitric oxide; GM-CSF; Granulocyte-macrophage colony-stimulating factor; ICS;
Keywords: اینترلوکین; CD; Crohn's disease; IBD; Inflammatory bowel disease; IBD-U; IBD-unclassified; IL; Interleukin; PGA; Physician global assessment; PIBDCRG; Pediatric Inflammatory Bowel Disease Collaborative Research Group; UC; Ulcerative colitis; VEO; Very early-onset;
Keywords: اینترلوکین; AAVA; anti-annexin V antibodies; AECA; anti-endothelial cell antibodies; Ang; angiopoietin; ANGPTL; angiopoietin-like protein; AT1R; antibodies against angiotensin II type 1 receptor; CCR; chemokine receptor; dcSSc; diffuse cutaneous systemic sclerosis; D
Keywords: اینترلوکین; ANOVA; analysis of variance; CCI; chronic constriction injury; IgG; immunoglobulin G; IL; Interleukin; IR; immunoreactivity; JOR; jaw-opening reflex; MOD; mean optical density; PWT; paw withdrawal threshold; RN; red nucleus; SNI; spared nerve injury; TGF-
Keywords: اینترلوکین; Ag; Antigen; DC; Dendritic cell; IL; Interleukin; LPS; Lipopolysaccharide; mDC; Myeloid dendritic cell; MHC; Major histocompatability complex; MoDC; Monocyte-derived dendritic cell; pDC; Plasmacytoid dendritic cell; poly(I:C); Polyinosinic:polycytidylic a
Keywords: اینترلوکین; ASCs; adipose stromal cells; CLS; crown-like structures; COX-2; cyclooxygenase-2; WAT; white adipose tissue; EP receptors; E prostanoid receptors; ER; estrogen receptor; IGF-I; insulin-like growth factor-I; NF-κB; nuclear factor kB; STAT3; signal transdu
Keywords: اینترلوکین; Bone regeneration; Hydroxyapatite; Stem cell; Silk; Interleukin; Osteogenesis;
Keywords: اینترلوکین; Cohort; C-reactive protein; Depression; Inflammation; Interleukin; Prospective;
Keywords: اینترلوکین; Major depression; Inflammation; Hypothalamic pituitary adrenal axis; Tumor necrosis factor; Interleukin;
Keywords: اینترلوکین; BMDCs; mouse bone marrow-derived dendritic cells; ELISA; enzyme-linked immunosorbent assay; FBS; foetal bovine serum; IL; interleukin; LPS; lipopolysaccharide; MHC; major histocompatibility complex; TNF; tumour necrosis factor; rmGM-CSF; recombinant murin
Keywords: اینترلوکین; Omega-6:omega-3; Nonalcoholic fatty-liver disease; High-fat diet; α-Linolenic acid; Colitis; Murine model; 4-HNE; 4-hydroxy-2-nonenal; AA; arachidonic acid; ALA; alpha-linolenic acid; ATF6; activating transcription factor 6; BiP; binding immunoglobulin p
Keywords: اینترلوکین; NAD+; nicotinamide adenine dinucleotide; SIRT; sirtuin; PARP; poly(ADP-ribose) polymerase; OHCs; outer hair cells; ROS; reactive oxygen species; NOX; NAD(P)H oxidases; TNF; tumor necrosis factor; RANTES; regulated on activation normal T-cell expressed and
Keywords: اینترلوکین; Antioxidant enzymes; Brain; Inflammation; Nanoparticles; Oxidative stress; Renin-angiotensin system; ACTB; beta actin; APP; amyloid β (A4) precursor protein; APx; ascorbic acid peroxidase; ARO; aromatase; ANG; angiotensin; ACE; angiotensin converting e
Keywords: اینترلوکین; AE; adverse event; BCVA; best-corrected visual acuity; CI; confidence interval; IL; interleukin; IV; intravenous; SC; subcutaneous; Th; T-helper; TNF; tumor necrosis factor;
Keywords: اینترلوکین; AD; autosomal dominant; AD-HIES; autosomal dominant hyper-immunoglobulin E syndrome; AR; autosomal recessive; BMD; bone mineral density; CMC; chronic mucocutaneous candidiasis; DOCK8; dedicator of cytokinesis 8; EBV; Epstein-Barr virus; FOXP3; forkhea
Keywords: اینترلوکین; AAG; autoimmune atrophic gastritis; AEA; anti-enterocyte antibody; AIE; autoimmune enteropathy; APECED; autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; ATP-ase; adenosine triphosphatase; CD; celiac disease; ECL; enterochromaffin-like;
Keywords: اینترلوکین; ACLF; acute-on-chronic liver failure; ALF; acute liver failure; HE; hepatic encephalopathy; GLS; glutaminase; ROS; reactive oxygen species; IL; interleukin; TNF; tumour necrosis factor; BT; bacterial translocation; SIBO; small intestinal bacterial overgro
Keywords: اینترلوکین; ACTH; adrenocorticotropic hormone; AFC; alveolar fluid clearance; ALI; acute lung injury; ARDS; acute respiratory distress syndrome; 11β-HSD; 11β-hydroxysteroid dehydrogenase; 11β-HSD1; 11β-hydroxysteroid dehydrogenase type 1; 11β-HSD2; 11β-hydroxys
Keywords: اینترلوکین; Akt; protein kinase B; BMDMs; bone marrow-derived macrophages; BSA; bovine serum albumin; cAMP; cyclic adenosine monophosphate; CCL; chemokine (C-C motif) ligand; CCR; C-C motif receptor; CD; cluster of differentiation; ConA; concanavalin A; CTL; cyto
Keywords: اینترلوکین; ANOVA; analysis of variance; DAB; diaminobenzidine tetrahydrochloride; DC; dendritic cell; ELISA; enzyme-linked immunoassay; Foxp3; forkhead box P3; IFN; interferon; IL; interleukin; I/R; ischemia/reperfusion; LV; lentiviral vector; mRNA; messenger ribonu
Keywords: اینترلوکین; BD; branch-duct; EUS; endoscopic ultrasound; FNA; fine-needle aspiration; IL; interleukin; IPMN; intraductal papillary mucinous neoplasm of the pancreas; MCN; mucinous cystic neoplasm; miRNA; micro-ribonucleic acid; MUCs; mucins; PDAC; pancreatic ductal a
Keywords: اینترلوکین; Blood-brain barrier; Neurovascular unit; Glycolysis; Lactate; Brain development; AGEs; advanced glycation end products; ADP; ribose-adenosine diphosphate ribose; ATP; adenosine triphosphate; BBB; blood-brain barrier; BDNF; brain-derived growth factor; C
Keywords: اینترلوکین; AMPK; AMP-activated protein kinase; ASK1; apoptosis signal-regulating kinase 1; Atg; autophagy-related; ARE; AU-rich element; AUF; ARE RNA binding protein; BRF; butyrate response factor; CaMK; Ca2Â +/calmodulin-dependent protein kinase; CUGBP; CUG-binding
Keywords: اینترلوکین; Ab; antibody; Ag; antigen; ALT; alanine aminotransferase; APCs; antigen presenting cells; AST; aspartate aminotransferase; a.u; arbitrary units; B. abortus; Brucella abortus; BSA; bovine serum albumin; CD; circular dichroism; CFSE; Carboxyfluorescein succ
Keywords: اینترلوکین; IL; interleukin; TNF-α; tumor necrosis factor α; IFN-γ; interferon γ; CRC; colorectal carcinoma; Adenoma; Carcinogenesis; Colorectum; Immunosurveillance; Immunosuppressive;
Keywords: اینترلوکین; RA; rheumatoid arthritis; DCs; dendritic cells; TolDCs; tolerogenic dendritic cells; NSAIDs; non-steroidal anti-inflammatory drugs; GC; glucocorticoids; DMARDs; disease-modifying anti-rheumatic drugs; TLRs; toll-like receptors; CLRs; cell surface C-type l
Keywords: اینترلوکین; complications; diabetes; inflammation; macrovascular; microvascular; observational study; psoriasis; AE; adverse event; CEPC; circulating endothelial progenitor cell; CI; confidence interval; HR; hazard ratio; IL; interleukin; TNF; tumor necrosis factor;
Keywords: اینترلوکین; APRIL; A proliferation inducing ligand; BAFF; B cell activating factor; DCF; Chloromethyl-dichlorofluorescein diacetate; CD; Crohn's disease; Ct; Comparative threshold cycle; CON; Control; DHA; Docosahexaenoic acid; Cdh1; E cadherin; EPA; Eicosapentaeno
Keywords: اینترلوکین; VEGF; vascular endothelial growth factor; TGF-β; transforming growth factor-β; ECM; extracellular matrix; EC; endothelial cell; SPARC; secreted protein acidic and rich in cysteine; PG; proteoglycan; GAG; glycosaminoglycan; SLRP; small leucine-rich prote
Keywords: اینترلوکین; BE; bland embolization; CI; confidence interval; GM-CSF; granulocyte-macrophage colony-stimulating factor; HR; hazard ratio; IL; interleukin; ORR; overall response rate; OS; overall survival; PFS; progression-free survival; PR; partial response; SD; sta
Keywords: اینترلوکین; ACTB; beta-actin; ATF4; activating transcription factor 4; BGLAP; osteocalcin; COL1A1; collagen type I alpha 1; FN1; fibronectin; IBSP; bone sialoprotein 2; IFN-γ; interferon-γ; IL; interleukin; RUNX2; runt-related transcription factor 2; SATB2; special